Cargando…
Clinical practice guidelines in Brazil – developing a national programme
In Brazil, governmental and non-governmental organisations develop practice guidelines (PGs) in order to optimise patient care. Although important improvements have been made over the past years, many of these documents still lack transparency and methodological rigour. In order to conduct a critica...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302389/ https://www.ncbi.nlm.nih.gov/pubmed/32552692 http://dx.doi.org/10.1186/s12961-020-00582-0 |
_version_ | 1783547836451782656 |
---|---|
author | Colpani, Verônica Kowalski, Sérgio Candido Stein, Airton Tetelbom Buehler, Anna Maria Zanetti, Daniel Côrtes, Gabriel de Melo Junior, Edison Vieira Ebeidalla, Jorgiany Emerick de Oliveira, Natiela Beatriz Guerra, Renata Leborato Silva, Sarah Nascimento Duncan, Bruce B. Falavigna, Maicon Schünemann, Holger Jens |
author_facet | Colpani, Verônica Kowalski, Sérgio Candido Stein, Airton Tetelbom Buehler, Anna Maria Zanetti, Daniel Côrtes, Gabriel de Melo Junior, Edison Vieira Ebeidalla, Jorgiany Emerick de Oliveira, Natiela Beatriz Guerra, Renata Leborato Silva, Sarah Nascimento Duncan, Bruce B. Falavigna, Maicon Schünemann, Holger Jens |
author_sort | Colpani, Verônica |
collection | PubMed |
description | In Brazil, governmental and non-governmental organisations develop practice guidelines (PGs) in order to optimise patient care. Although important improvements have been made over the past years, many of these documents still lack transparency and methodological rigour. In order to conduct a critical analysis and define future steps in PG development in Brazil, we carried out a structured assessment of strengths, weaknesses, opportunities and threats (SWOT analysis) for the development of a national guideline programme. Participants consisted of academia, methodologists, medical societies and healthcare system representatives. In summary, the PG development process has improved in Brazil and current investments in methodological research and capacity-building are ongoing. Despite the centralised processes for public PGs, standardised procedures for their development are not well established and human resources are insufficient in number and capacity to develop the amount of trustworthy documents needed. Brazil’s capacity could be strengthened and initial efforts have been made such as the adoption of standards proposed by world-renowned institutions in PG development and enhancement of the involvement of key stakeholders. Further steps involve the alignment between health technology assessment and PG processes for synergy and the development of a national network to promote the interaction between groups involved in the development of PGs. The lessons learned from this paper could be used to foster debate on guideline development, especially for countries facing similar threats on this topic. |
format | Online Article Text |
id | pubmed-7302389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73023892020-06-19 Clinical practice guidelines in Brazil – developing a national programme Colpani, Verônica Kowalski, Sérgio Candido Stein, Airton Tetelbom Buehler, Anna Maria Zanetti, Daniel Côrtes, Gabriel de Melo Junior, Edison Vieira Ebeidalla, Jorgiany Emerick de Oliveira, Natiela Beatriz Guerra, Renata Leborato Silva, Sarah Nascimento Duncan, Bruce B. Falavigna, Maicon Schünemann, Holger Jens Health Res Policy Syst Commentary In Brazil, governmental and non-governmental organisations develop practice guidelines (PGs) in order to optimise patient care. Although important improvements have been made over the past years, many of these documents still lack transparency and methodological rigour. In order to conduct a critical analysis and define future steps in PG development in Brazil, we carried out a structured assessment of strengths, weaknesses, opportunities and threats (SWOT analysis) for the development of a national guideline programme. Participants consisted of academia, methodologists, medical societies and healthcare system representatives. In summary, the PG development process has improved in Brazil and current investments in methodological research and capacity-building are ongoing. Despite the centralised processes for public PGs, standardised procedures for their development are not well established and human resources are insufficient in number and capacity to develop the amount of trustworthy documents needed. Brazil’s capacity could be strengthened and initial efforts have been made such as the adoption of standards proposed by world-renowned institutions in PG development and enhancement of the involvement of key stakeholders. Further steps involve the alignment between health technology assessment and PG processes for synergy and the development of a national network to promote the interaction between groups involved in the development of PGs. The lessons learned from this paper could be used to foster debate on guideline development, especially for countries facing similar threats on this topic. BioMed Central 2020-06-17 /pmc/articles/PMC7302389/ /pubmed/32552692 http://dx.doi.org/10.1186/s12961-020-00582-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Colpani, Verônica Kowalski, Sérgio Candido Stein, Airton Tetelbom Buehler, Anna Maria Zanetti, Daniel Côrtes, Gabriel de Melo Junior, Edison Vieira Ebeidalla, Jorgiany Emerick de Oliveira, Natiela Beatriz Guerra, Renata Leborato Silva, Sarah Nascimento Duncan, Bruce B. Falavigna, Maicon Schünemann, Holger Jens Clinical practice guidelines in Brazil – developing a national programme |
title | Clinical practice guidelines in Brazil – developing a national programme |
title_full | Clinical practice guidelines in Brazil – developing a national programme |
title_fullStr | Clinical practice guidelines in Brazil – developing a national programme |
title_full_unstemmed | Clinical practice guidelines in Brazil – developing a national programme |
title_short | Clinical practice guidelines in Brazil – developing a national programme |
title_sort | clinical practice guidelines in brazil – developing a national programme |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302389/ https://www.ncbi.nlm.nih.gov/pubmed/32552692 http://dx.doi.org/10.1186/s12961-020-00582-0 |
work_keys_str_mv | AT colpaniveronica clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT kowalskisergiocandido clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT steinairtontetelbom clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT buehlerannamaria clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT zanettidaniel clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT cortesgabriel clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT demelojunioredisonvieira clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT ebeidallajorgianyemerick clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT deoliveiranatielabeatriz clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT guerrarenataleborato clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT silvasarahnascimento clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT duncanbruceb clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT falavignamaicon clinicalpracticeguidelinesinbrazildevelopinganationalprogramme AT schunemannholgerjens clinicalpracticeguidelinesinbrazildevelopinganationalprogramme |